Immunexpress Announces Presentation at the 36th International Symposium on Intensive Care and Emergency Medicine on the Need for an Objective Diagnostic Tool for Systemic Inflammation

Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced that data from the VENUS trial showing the discordance between clinical impressions of patients with systemic inflammation will be presented at the upcoming 36th International Symposium on Intensive Care and Emergency Medicine on Mar. 15 in Brussels, Belgium.